Generic drug
Ketorolac price, strengths & recalls
Pharmacies pay $5.11 for 30 tablets of Ketorolac 10 mg tablet this week, and from $5.11 to $63.09 across its 5 priced strengths and forms. 57 manufacturers make it. It is in shortage (unavailable). 12 recalls are ongoing. Its official label last changed on October 26, 2026.
Unavailable12 open recallsGeneric- Fair cash price
- $16.38
- Strengths
- 5
- Makers
- 57
- Updated
- Nov 11
Ketorolac price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 4 mg/mL eye drops | $12.62 | $63.09 / 5 mL | ||
| 5 mg/mL eye drops | $1.16 | $5.82 / 5 mL | ||
| 15 mg/mL, 1 mL injection | Not priced this week | |||
| 30 mg/mL, 1 mL injection | $1.00 | $25.11 / 25 mL | ||
| 30 mg/mL, 2 mL injection | $0.6167 | $30.83 / 50 mL | ||
| 10 mg tablet | $0.1703 | $5.11 / 30 tablets | ||
The lowest cost per tablet is 10 mg tablet at $0.1703. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Brand names of ketorolac
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
Shortages
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
- Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)Next Delivery and Estimated Recovery: December 2027
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)Estimated recovery: Mid-November 2026, Product in transit and expected to arrive week of Nov 12th
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)Product in transit with expected delivery in December 2026
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)Estimated recovery: TBD
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)Next release not available at this time. Check wholesalers for inventory.
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)Next release not available at this time. Check wholesalers for inventory.
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)Estimated recovery: December 2026
- Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)Estimated recovery: TBD
In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.
Recalls
Showing the 6 most relevant of 54 - all recalls.
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Ketorolac
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
Ketorolac Tromethamine Tablets USP, 10mg Rx only
WARNING
Ketorolac tromethamine tablets, a nonsteroidal anti-inflammatory drug (NSAID), are indicated for the short-term (up to 5 days in adults), management of moderately severe acute pain that requires analgesia at the opioid level and only as continuation treatment following IV or IM dosing of ketorolac tromethamine, if necessary. The total combined duration of use of ketorolac tromethamine tablets and ketorolac tromethamine should not exceed 5 days.
Ketorolac tromethamine tablets are not indicated for use in pediatric patients and they are NOT indicated for minor or chronic painful conditions. Increasing the dose of ketorolac tromethamine tablets beyond a daily maximum of 40 mg in adults will not provide better efficacy but will increase the risk of developing serious adverse events.
GASTROINTESTINAL RISK
Ketorolac tromethamine, including ketorolac tromethamine tablets can cause peptic ulcers, gastrointestinal bleeding and/or perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Therefore, ketorolac tromethamine is CONTRAINDICATED in patients with active peptic ulcer disease, in patients with recent gastrointestinal bleeding or perforation, and in patients with a history of peptic ulcer disease or gastrointestinal bleeding. Elderly patients are at greater risk for serious gastrointestinal events (see
WARNINGS).
CARDIOVASCULAR THROMBOTIC EVENTS
Nonsteroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use (see
WARNINGSand
PRECAUTIONS).
Ketorolac tromethamine tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surgery (see
CONTRAINDICATIONSand
WARNINGS).
RENAL RISK
Ketorolac tromethamine is CONTRAINDICATED in patients with advanced renal impairment and in patients at risk for renal failure due to volume depletion (see
WARNINGS).
RISK OF BLEEDING
Ketorolac tromethamine inhibits platelet function and is, therefore, CONTRAINDICATED in patients with suspected or confirmed cerebrovascular bleeding, patients with hemorrhagic diathesis, incomplete hemostasis and those at high risk of bleeding (see
WARNINGSand
PRECAUTIONS).
Ketorolac tromethamine is CONTRAINDICATED as prophylactic analgesic before any major surgery.
RISK DURING LABOR AND DELIVERY
The use of ketorolac tromethamine in labor and delivery is contraindicated because it may adversely affect fetal circulation and inhibit uterine contractions.
CONCOMITANT USE WITH NSAIDs
Ketorolac tromethamine is CONTRAINDICATED in patients currently receiving aspirin or NSAIDs because of the cumulative risk of inducing serious NSAID-related side effects.
SPECIAL POPULATIONS
Dosage should be adjusted for patients 65 years or older, for patients under 50 kg (110 lbs) of body weight (see
DOSAGE AND ADMINISTRATION) and for patients with moderately elevated serum creatinine (see
WARNINGS).
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA021528 · Abbvie
- First approved
- May 30, 2003 (23 years ago)
- Latest approved change
- March 5, 2021
- Approved label
- PDF, Mar 9, 2021
- Generic makers
- 26 approved generic applications on the market
- Last patent listed
- November 24, 2027
Ketorolac questions
How much does ketorolac cost without insurance?
Pharmacies pay about $5.11 for 30 tablets of ketorolac 10 mg tablet ($0.1703 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $16.38. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of ketorolac?
Is ketorolac in shortage?
Yes. 26 products are listed as in shortage or being discontinued (unavailable). See which ones.
Has ketorolac been recalled?
54 recalls on record, 12 ongoing. Recalls name specific lots - check yours.
When did the ketorolac label last change?
The official label was last updated on October 26, 2026 (version 6). See what changed.
Talk about ketorolac
No comments yet. Questions, tips, what worked for you - start the conversation.